Webcasts & Presentations

Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

April 10, 2024

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results

SAN DIEGO, Apr. 10, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on May 1, 2024.

Corporate Presentation Link Placeholder (Available May 1, 2024 at 7:00 a.m. Eastern Time)

OPEN WEBCAST
March 18, 2024

Neurocrine Biosciences to Particpate at the UBS Virtual CNS Day 2024 Conference

Eiry Roberts, Chief Medical Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the UBS Virtual CNS Day Conference at 12:00 p.m. Eastern Time on Monday March 18, 2024.

OPEN WEBCAST
March 19, 2024

Neurocrine Biosciences to Particpate at the Stifel 2024 Virtual CNS Days Conference

Kyle Gano, Chief Business Development and Strategy Officer, and Grace Liang, Vice President of Clinical Development, will present at the Stifel 2024 Virtual CNS Days Conference at 2:00 p.m. Eastern Time on Tuesday March 19, 2024.

OPEN WEBCAST
Resources

Email Alerts

To stay up to date on Neurocrine Biosciences, please sign up for our email alerts.

Sign Up Now